Keeping you up to date on recent developments in orthopedics, including: Implanted neural stem cell grafts show functionality in spinal cord injuries; Silk scaffolds and magnetism to generate bone tissue and be able to use it in implants; Hydrogel paves way for biomedical breakthrough; New strategy against osteoporosis.
Keeping you up to date on recent developments in oncology, including: Cancer follow-up plummeted in Wuhan after onset of COVID-19 pandemic; T-cell receptor sequencing proves useful for tracking thyroid cancer; Silver nanowires take their place in brain cancer therapy.
Keeping you up to date on recent developments in cardiology, including: Genetic variants contribute to heightened death risk from stroke in those of African descent; Pathologists publish report on likely MIS involving the heart; Studying COVID-19’s impact on the heart.
Keeping you up to date on recent developments in neurology, including: Quanterix biomarker technology used to measure neuronal injury in COVID-19 patients; AI could speed up and improve Alzheimer's diagnosis; Mental fatigue of MS linked to inefficient recruitment of neural resources.
Keeping you up to date on recent developments in diagnostics, including: Expanding sampling options for COVID-19 could increase testing; Envisia classifier improves IPF diagnosis; Structural study gives insight into plaque formation.
Keeping you up to date on recent developments in orthopedics, including: Lego-inspired bone and soft tissue repair with tiny, 3D-printed bricks; Mutant zebrafish reveals a turning point in spine's evolution; Newly discovered cells act as a warning signal for rheumatoid arthritis flares.
Researchers from the Encyclopedia of DNA Elements (ENCODE) consortium reported data from the third phase of the project. Phase III data, which were published in more than a dozen papers in Nature and its sister journals on July 29, 2020, consisted of 6,000 experiments performed on around 1,300 samples.
CYBERSPACE – Data presented at the virtual 2020 Alzheimer's Association International Conference (AAIC) and reported in the July 28, 2020, online issue of the Journal of the American Medical Association (JAMA) demonstrated that blood levels of phosphorylated tau-217 (Ptau-217) did as well as cerebrospinal (CSF)- and PET-based biomarkers, and significantly better than other blood-based biomarkers, at discriminating individuals with Alzheimer’s disease (AD) from those with other neurodegenerative disorders.
Keeping you up to date on recent developments in oncology, including: ctDNA associated with poor outcomes in triple-negative breast cancer; Protons beat IMRT for locally advanced esophageal cancer; Study affirms cancer patients avoiding clinical care.
RSS
